Balchem Corporation achieved record consolidated net sales and earnings for the third quarter of 2026, supported by organic growth across its entire portfolio. Results were characterized by significant margin expansion and record performance in the Human Nutrition and Health segment.
Key Highlights
- Human Nutrition and Health segment sales reached a record $188.2 million, an 8.1% increase year-over-year driven by nutrients and food ingredients.
- Animal Nutrition and Health revenue grew 11.7% to $63.0 million, reflecting higher volume in monogastric and ruminant markets.
- Consolidated gross margin expanded 70 basis points to 36.4% due to favorable product mix and improved manufacturing efficiencies.
- Shareholder returns continued through the repurchase of $27.4 million in common stock while maintaining a low net leverage ratio of 0.2x.